(Q34074654)

English

Novel therapy for COPD.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Novel therapy for COPD. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Trevor T. Hansel

3

object named as

Hansel TT

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Leckie MJ

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Bryan SA

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Barnes PJ

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

number of pages

21

1 reference

based on heuristic

inferred from page(s)

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3-23

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Worldwide epidemiology of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

The global burden of disease, 1990–2020

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Dietary antioxidant vitamin intake and lung function in the general population

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Perforin and lymphocyte-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Oxidative Stress in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Metalloproteinase inhibitors and the prevention of connective tissue breakdown

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

The matrix metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Matrix metalloproteinases: a role in emphysema?

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Matrix metalloproteases and lung disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Epithelial mucin genes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Dose response relation to oral theophylline in severe chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

EUROSCOP, ISOLDE and the Copenhagen city lung study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Nicotine medications for smoking cessation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Blockade of nicotine self-administration with nicotinic antagonists in rats.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Prospects for improved therapy in chronic obstructive pulmonary disease by the use of levalbuterol

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Muscarinic receptor subtypes in airways

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Opportunities for novel therapeutic agents acting at chemokine receptors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Interleukin-10: an anti-inflammatory cytokine with therapeutic potential

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Molecular mechanisms of steroid action in asthma

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Anti-inflammatory actions of steroids: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and in the rat in vivo

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Characterization of the radical trapping activity of a novel series of cyclic nitrone spin traps

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

ONO-5046, a novel inhibitor of human neutrophil elastase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Biochemical and pharmacological characterization of FR134043, a novel elastase inhibitor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

IL-12: a key cytokine in immune regulation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

'Sensory-efferent' neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Opioid inhibition of neurally mediated mucus secretion in human bronchi

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Inhibition of Neutrophil Serine Proteinases by Suramin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Epithelial Permeability, Inflammation, and Oxidant Stress in the Air Spaces of Smokers

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

N‐isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.3

21 January 2018

Identifiers

10.1517/13543784.9.1.3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34074654&oldid=1968074535"